European Editorial Board
Associate Professor, Department Electronics, Information and Bioengineering (DEIB), Politecnico di Milano
Andrea Aliverti is associate Professor at the Department Electronics, Information and Bioengineering (DEIB), Politecnico di Milano where he teaches Sensors and Instrumentation Technologies and Bioengineering of the Respiratory System. Since 2014, he is the chairman of the PhD Programme in Bioengineering at the Politecnico di Milano. He is responsible of Respiratory Analysis Lab at the Biomedical Technology Laboratory. His actual main research interests include the bioengineering of the respiratory system, physiological measurements; biomedical instrumentation and sensors; lung imaging (multivolume registration for the functional analysis of lung by CT and MRI, ultrasonography of the diaphragm; in-vivo microscopic imaging of alveolar and pulmonary vessels geometry), electrical impedance spectroscopy and monitoring of physiological variables by means of wearable unobtrusive sensors.
He is author of 130 papers in peer-reviewed scientific journals, 8 book chapters, editor of 3 books, inventor in 13 patents. He is member of the editorial board of several scientific journals and an active member of the European Respiratory Society (ERS). Currently, he is secretary of the Assembly “Clinical Physiology, Sleep and Pulmonary Circulation”, member of the ERS Education Council, Chairman of the ERS Task Force ‘Functional evaluation of lung and airways’.
Director of the Post-Graduate School in Respiratory Diseases, University of Insubria, Varese, Italy
Prof. Spanevello trained and developed his career in one of the most prestigious and competitive Italian University, the University of Pavia, and spent time as a visiting clinical research fellow with Dr Philip Ind and Prof. Neil Pride at Hammersmith Hospital in London in 1994-1995, where he performed important studies on induced sputum analysis in asthma.
Since then he’s been involved in a variety of clinical and translational research on the pathogenesis and clinical aspects of allergic respiratory diseases, asthma and COPD. He has a comprehensive approach to research on asthma and COPD, particularly with human studies to explore the role of inflammation (and particularly allergic inflammation) assessed with non-invasive methods, particularly sputum.
In addition to his academic activities in the University of Insubria, Varese, he has taken major managerial responsibilities by becoming Director of the Department of Respiratory Diseases of the Maugeri Foundation in Italy, where he is the Director of the Respiratory Unit of Tradate (Varese), but also of the 8 Respiratory Units of the Maugeri Foundation, ie a department of more than 200 beds.
He is the Editor of the Monaldi Archives of Chest Diseases, which is the leading respiratory journal in Italy.
He is a very active member of the ERS and is currently Secretary of the Airway Disease Assembly.
He is invited to actively participate with lectures or as a chair in more than 30 national and international conferences each year and is often interviewed by local and national newspapers and TV programs to speak on topics related to respiratory diseases.
Professor of clinical pharmacology and respiratory medicine, Medicines Evaluation Unit (MEU), University Hospital Of South Manchester NHS Foundation Trust, Manchester, UK
After graduating from Cambridge University, he trained in respiratory medicine and clinical pharmacology in Manchester. He was appointed Professor of Clinical Pharmacology and Respiratory Medicine at the University of Manchester in 2011. His research interests are the pharmacotherapy of asthma and COPD, with studies spanning from basic pharmacology of anti-inflammatory drugs to clinical trials. He has acted as principal investigator on numerous clinical trials of novel therapies in asthma and COPD, and has over 130 publications in peer reviewed journals. He is a member of the GOLD science committee.
Assistant Professor in Respiratory Medicine, Humanitas University of Milan, Italy
Enrico Heffler is Assistant Professor in Respiratory Medicine at Humanitas University of Milan, Italy and consultant at the Personalized Medicine, Asthma & Allergy Unit of the same institution. He is an Allergist and Clinical Immunologist with a research interest mainly in the field of asthma and other inflammatory airway diseases; in particular, his research is currently on severe asthma and its inflammatory mechanisms. He is author of more than 90 articles published in peer-reviewed journals. He is currently an elected member of the European Academy of Allergy and Clinical Immunology (EAACI) Asthma Section Board.
University of Rome "La Sapienza"
Prof. Fabio Midulla is Associate Professor of Paediatrics at the “Sapienza” University of Rome. He has been working in Pediatric pulmonology since the last 30 years. He is the author of more than 80 publications in peer-review journals. Prof. Midulla’s main activities in research are on Bronchoalveolar lavage in children and on acute bronchiolitis. He is the head of the paediatric Assembly of the European Respiratory Society.
Professor of Respiratory Cell and Molecular Biology, Faculty of Medicine, National Heart & Lung Institute, Imperial College London, UK
Ian Adcock is Professor of Respiratory Cell & Molecular Biology and Head of the Molecular Cell Biology Group at the National Heart & Lung Institute, Imperial College London. He also holds an honorary research position at the Royal Brompton Hospital enabling him to translate the basic research activities into the clinical environment.
Professor Adcock obtained a degree in Biochemistry & Physiology from the University of London and later a PhD in Pharmacology from St Thomas''s Hospital London on the role of nuclear receptors on sexual dimorphic patterns in the rat. He performed postdoctoral training at the MRC Brain Metabolism Unit with Professors Tony Harmar and George Fink and in the Protein Science Laboratory at St Georges’ Hospital with Professor Brian Austen. He joined Professor Peter Barnes at the National Heart & Lung Institute in 1990 to undertake research on the effects of corticosteroids on inflammatory mediators in asthma and COPD. This remains his major research area along with a long-term interest in the mechanisms underlying relative steroid insensitivity in severe asthma and COPD.
Professor Adcock is an internationally recognized scientist in the field of airways disease and inflammation. He has authored and co-authored over 230 scientific articles and has served on the editorial boards of several journals. He has worked as an expert member on national grant-awarding organizations including UK MRC, US NIH, Australian NHMRC and Canadian MRC. He has served on the ERS Council and is currently a member of the ERS Scientific Program Committee and Head of the ERS Airway Pharmacology and Treatment Section.
Professor Adcock is a principal investigator in the Medical Research Council/Asthma UK Centre in Allergic Mechanisms of Asthma and in the Wellcome Trust Respiratory Infections Centre. His research is currently funded by grants from the Medical Research Council, Wellcome Trust, BHF, Royal Society, EU, BBSRC, EPSRC and Industrial collaborators. He is also a principal investigator in the European consortium UBIOPRED on mechanisms of severe asthma that is funded through the Innovative Medicine Initiative of the European Union and EFPIA.
Medical Adviser, TB competence Centre, Swiss Lung Association
Jean-Pierre Zellweger is a swiss pulmonary physician, with clinical experience in the management of chronic respiratory diseases, smoking cessation and tuberculosis. He was senior consultant at the University Hospital Medical Policlinic (TB department) in Lausanne. He is now medical adviser for the Swiss Lung Association, interacting with Swiss and international organizations involved in the management of tuberculosis.
Chest Physician and Senior Researcher, Department of Pneumology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
Marc Miravitlles is a pulmonologist working in clinical research in the Hospital Universitari Vall d’Hebron in Barcelona, Spain. His primary research interests include chronic obstructive pulmonary disease (COPD), chronic bronchitis, alpha-1-antitrypsin deficiency (AAT), lung defence mechanisms and respiratory infections.
He serves on various medical committees and is a member of numerous professional societies, including the Spanish Society of Pneumology and Thoracic Surgery (SEPAR), where he served as Secretary from 1999 until 2003 and as responsible for International Relationships from 2006 to 2011. Dr. Miravitlles has acted as chair of the Respiratory Infections group of the European Respiratory Society (ERS) from 2008 to 2011. He has acted as a consultant for the development of different international guidelines of COPD, such as the American Thoracic Society/European Respiratory Society task force on outcomes in COPD. He was also a consultant of the Spanish Ministry of Health for the development of the National Strategy against COPD (2009 onwards). He is the coordinator of the Spanish National Guidelines for COPD (GesEPOC 2012 and update 2014). Dr Miravitlles has published numerous articles in a number of peer-reviewed international medical journals largely related to COPD, infection in COPD and alpha-1-antitrypsin deficiency.
Professor of Respiratory Medicine and Director of the Postgraduate School of Respiratory Medicine, University of Rome ‘Tor Vergata’, Rome, Italy
Mario Cazzola is Honorary Professor of Respiratory Medicine at the University of Rome Tor Vergata and Visiting Professor at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK. He is the author or a co-author of about 600 papers mainly focused on pharmacotherapy of COPD. Prof. Cazzola is serving as Editor-in-chief of Pulmonary Pharmacology & Therapeutics and of COPD – Research and Practice and as an Associate Editor of Respiratory Medicine and Respiratory Research. He is a member of the Editorial Boards of Lancet Respiratory Medicine, Drugs, Respiration, COPD, International Journal of Chronic Obstructive Pulmonary Disease, and npj Primary Care Respiratory Medicine. Prof. Cazzola is a fellow of the European Respiratory Society in which he is now the Internal Auditor. He has received the 2015 European Respiratory Society Lifetime Achievement Assembly Award.
Specialist in Allergy and Clinical Immunology and on Health Units Management, is the Head of the Allergy Center of CUF-Descobertas Hospital and CUF-Infante Santo Hospital in Lisbon and Researcher of CINTESIS – Center for Health Technology and Services Research, Porto Medical School, Portugal.
His primary research interests include asthma, rhinitis, epidemiology and environmental risk factors for asthma and other allergic diseases, from pre-school age to the elderly.
He serves on various medical committees and is a member of several professional societies, international and national, including the Portuguese Society of Allergy and Clinical Immunology, where he served as President from 2005 until 2013. Dr. Morais-Almeida is the Vice-president of the Portuguese Association of Asthmatic and Allergic Patients, and has acted as Vice-president of the Latin American Allergy, Asthma and Immunology Society - SLAAI (2013-2015), President of the South European Allergy Societies - SEAS (2011), Vice-president of the Lung Portuguese Foundation (2010-2012), President of the Luso-Brazilian Society of Allergy and Clinical Immunology - SLBAIC (2009-2010) and President of the Allergy and Clinical Immunology Board of the Portuguese Medical Association (2003-2006). He act as a consultant of several departments of the Portuguese Ministry of Health for the development of the national strategy namely against asthma and anaphylaxis. He published more than 150 articles in peer-reviewed national and international medical journals largely related to asthma, rhinitis and epidemiology.
Consultant Thoracic Surgeon, University College London Hospitals UCLH, London
Nikolaos Panagiotopoulos MD PhD is a consultant Thoracic Surgeon at University College London Hospitals UCLH. His main interest is minimally invasive Thoracic Surgery including Robotic Thoracic Surgery. He has 37 publications in peer-reviewed journals, 3 chapters in books and significant number of national and international presentations in minimally invasive Thoracic Surgery.
Margaret-Turner Warwick Professor of Medicine, National Heart and Lung Institute, Head of Respiratory Medicine, Imperial College, London, UK
Peter Barnes is Margaret-Turner Warwick Professor of Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities (first class honours) and was appointed to his present post in 1987. He has published over 1000 peer-review papers on asthma, COPD and related topics (h-index 151) and has written or edited over 50 books. He is the 7th most highly cited researcher in the world, has been the most highly cited clinical scientist in Europe and the most highly cited respiratory researcher in the world over the last 20 years. He was elected a Fellow of the Royal Society in 2007, the first respiratory researcher for over 150 years. He has given several prestigious lectures, including Amberson Lecture at ATS and Sadoul Lecture at ERS. He was President of the ERS in 2013/2014.
US Editorial Board
Brian W Carlin, MD, FCCP, FAARC, MAACVPR
Pulmonologist, Sleep Medicine and Lung Health Consultants LLC, and Pittsburgh Critical Care Associates, Pittsburgh, PA
Dr Carlin currently practices pulmonary, critical care, and sleep medicine in Pittsburgh Pennsylvania. He is a graduate of the Pennsylvania State University College of Medicine and completed his internship/residency/chief residency at Allegheny General Hospital in Pittsburgh. He then completed a pulmonary and critical care medicine fellowship at the University of California San Diego.
He is currently employed by Pittsburgh Critical Care Associates and by Sleep Medicine and Lung Health Consultants. He is a senior staff physician at UPMC Altoona Regional Medical Center where he attends in the critical care units. He is the Medical Director for both Lifeline Sleep Disorders Centers as well as Lifeline Pulmonary Rehabilitation Centers.
Dr Carlin is a former Training Program Director for pulmonary and critical care medicine fellows at Allegheny General Hospital. He expanded the training program during his tenure to include a training program in critical care medicine. He is also a former Past President of the National Association for Pulmonary and Critical Care Medicine Training Program Directors.
Dr Carlin has been active in other national and regional organizations during his career. He is a Past President of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) and is a former Associate Editor for the Journal of Cardiac and Pulmonary Rehabilitation and Prevention. He is the current Chairperson of the National Lung Health Education Program (NLHEP) and is a member of the board of the National Board for Respiratory Care (NBRC).
He is the former Chair of the Education Committee for the American College of Chest Physicians and is a current member of two networks within that organization (Pulmonary Function, Physiology, and Rehabilitation Network and the Interdisciplinary Team Network). He is a former board member of the CHEST Foundation and was the Program Chairperson for the CHEST 2007 annual meeting. He is the former Chair for the Training and Transition Committee for the American Thoracic Society and is the chair-elect for the Pulmonary Rehabilitation Assembly annual meeting.
Dr Carlin has been actively involved in scholarly activities in the field primarily with COPD, 30-day readmission rates, and pulmonary rehabilitation. He was a member of the 1997 and 2007 Evidence Based Guidelines for Pulmonary Rehabilitation (a conjoint project of the ACCP and the AACVPR) and has been a participant in recently released guidelines (ATS/ERS) for pulmonary rehabilitation as well as the timed walk test. He is the current co-Chair for the upcoming 4th edition of the Pulmonary Rehabilitation Guidelines for the AACVPR. He has coauthored many papers including those in the field of core competencies for pulmonary rehabilitation professionals, comorbidities for COPD, and roles and responsibilities for the pulmonary rehabilitation medical director. He is also a participant in the upcoming individual certification program for pulmonary rehabilitation professionals.
He has helped to develop two successful 30-day readmission reduction programs for patients who have been hospitalized with COPD exacerbations in the western Pennsylvania area. These programs have resulted in a decrease in the 30-day readmission rates for patients with COPD and heart disease by 25%. He is currently interested in the development of educational programs for professionals in the fields of performance of spirometry and the use of devices for inhaled medication delivery.
Daniel R. Ouellette
Associate Professor of Medicine, Wayne State University School of Medicine, in Detroit, Michigan
David Gozal, MD, MBA
Herbert T Abelson Professor, Department of Pediatrics, University of Chicago
Dr Gozal is currently the Herbert T Abelson Professor at the University of Chicago, where he also holds the title of Pritzker Scholar. He received his MD from the Hebrew University of Jerusalem, completed his pediatric residency at the Haifa Medical Center in Israel, and then spent 2 years in Cameroon, West Africa, developing rural healthcare networks, for which he received the title of “Knight of the Order of Merit”. He then completed his pediatric pulmonology and sleep medicine training at Children's Hospital of Los Angeles in 1993, and joined the faculty at the University of Southern California and UCLA. In 1994, he moved to Tulane University, and was appointed tenured Professor and Constance Kaufman Endowed Chair in Pediatric Pulmonology Research. From 1999–2009, Dr Gozal was at the University of Louisville as the Children’s Hospital Foundation Chair for Pediatric Research, Distinguished University Scholar, Director of the Kosair Children’s Research Institute, and Chief of the Division of Pediatric Sleep Medicine and the Sleep Medicine Fellowship Program, both of which were recognized as programs of distinction by the American Academy of Sleep Medicine. In 2009, Dr Gozal joined the University of Chicago as Chairman of the Department of Pediatrics and Physician-in-Chief of Comer Children’s Hospital.
Dr Gozal’s research interests include projects such as gene and cellular regulation in hypoxia and sleep disruption, murine models of sleep disorders, and genomic and proteomic approaches to clinical and epidemiological aspects of sleep in children.
He is the current President of the American Thoracic Society, was a member of the Board of Directors of the Sleep Research Society 2014–2016, is Editor-in-Chief of the Journal of Child Science, Deputy Editor for the journals Sleep and Frontiers in Neurology, and a regular member of the NNRS study section at NIH. He has been the recipient of the ATS Amberson Lecture in 2002, and most recently was awarded the William C. Dement Academic Achievement Award by the American Academy of Sleep Medicine in 2013 and the 2016 Lifetime Achievement Award of the National Sleep Foundation. His research work is supported by grants from the NIH, he has published >575 peer-reviewed original articles, >130 book chapters and reviews, 3 books, and >850 scientific abstracts, and has extensively lectured all over the world.
John Davies, MA, RRT, FAARC
Clinical Research Coordinator, Adult Critical Care at Duke Medical Center
Juzar Ali, MD, FRCP(C), FCCP
Klein Professor of Medicine, Section Pulm/CC/A&I and Director, Wetmore Mycobacterial Disease Program at LSU Health Sciences Center, New Orleans
Nicola Hanania, MD, MS
Associate Professor of Medicine, Pulmonary and Critical Care Medicine, and Director of the Airways Clinical Research Center, Baylor College of Medicine, Houston
Nicola A Hanania, MD, MS is Associate Professor of Medicine in the Section of Pulmonary and Critical Care Medicine and Director of the Airways Clinical Research Center at the Baylor College of Medicine in Houston, Texas, USA. He completed his medical training at the University of Jordan followed by residency in internal medicine and a fellowship in pulmonary medicine at the University of Toronto, Canada. He subsequently completed a fellowship in critical care medicine at Baylor College of Medicine, where he later earned a master’s degree in clinical investigation.
As a Fellow of the American College of Chest Physicians, Dr Hanania has served on the Board of Regents and as Chair of the Clinical Pulmonary, Airways Networks and Council of Networks for this organization. He has been on the Board of Trustees of the Chest Foundation since 2012. In addition, he is a current member of the Health Policy Committee of the American Thoracic Society, the European Respiratory Society, the Society of Critical Care Medicine and a fellow of the Royal College of Physicians and Surgeons of Canada. He has served on several guideline and workshop panels including the ACP/ATS/ACCP/ERS Clinical Practice guidelines on COPD and the CTS/ACCP COPD exacerbations guidelines.
Dr Hanania has received multiple awards including the ACCP’s Distinguished Scholar in Respiratory Health, ACCP Humanitarian Award, Career Investigator Award (K23) from the NIH, Fulbright and Jaworski’s Faculty Excellence Award for Teaching and Evaluation and the Award for Excellence in Teaching from the Department of Medicine at Baylor. Baylor also named him to the Academy of Distinguished Educators for 2003–2010. Dr Hanania is a Deputy Editor of Respiratory Medicine and is Associate Editor of Therapeutic Advances in Respiratory Disease, Current Opinion in Pulmonary Medicine (Asthma Section) and Pulmonary Pharmacology and Therapeutics.
Dr Hanania’s research interests focus on the pharmacology and management of asthma and COPD. He has published more than 200 peer-reviewed papers, book chapters, editorials and reviews on these topics. He is actively involved in clinical trials investigating novel treatments. He is Principal Investigator for the American Lung Association Airway Clinical Research Center at Baylor College of Medicine, as well as Principal Investigator or Co-Investigator in several clinical trials in asthma and COPD. He has been invited and has lectured widely at local, regional, national and international meetings.
Terrence Trow, MD
Director of the Pulmonary Vascular Disease Program, Yale University School of Medicine
Dr. Trow received his A.B. degree from Bowdoin College graduating summa cum laude and Phi Beta Kappa with highest honors in Biochemistry in 1982. He subsequently matriculated at Dartmouth Medical School, earning his MD in 1986 after being elected to the Alpha Omega Alpha Society. After a year of internship at the Hospital of the University of Pennsylvania in Philadelphia he completed his internal medicine training at The New York Hospital of the Cornell University Medical College in 1989. After a brief period as a junior faculty member at Columbia College of Physicians and Surgeons in the Emergency Medicine Division, he pursued his fellowship training at Yale University in the Section of Pulmonary and Critical Care finishing in 1993. After 9 years of service at Danbury Hospital, where he was an integral member of the house staff teaching core faculty, he was recruited to establish and build the Pulmonary Hypertension Center at Winthrop-University Hospital in Mineola, NY, an affiliate of the State University of New York at Stony Brook from 2002-2005 before being recruited to due the same at Yale University School of Medicine where he currently holds the title of Director of the Pulmonary Vascular Disease Program as well as Associate Professor of Medicine.
Dr. Trow has won a number of teaching awards including Attending of the Year at Danbury Hospital as well as Attending of the Year at Winthrop-University Hospital and has been appointed Fellow of the American College of Physicians and the American College of Chest Physicians. He served as a Deputy Editor of The Proceedings of the American Thoracic Society and served on the editorial board of Clinical Pulmonary Medicine. He is an invited reviewer for such journals as Annals of Internal Medicine, Chest, the American Journal of Respiratory and Critical Care Medicine, Heart & Lung, Southern Medical Journal, Clinical Pulmonary Medicine, and the Annals of the American Thoracic Society, Drug Design, Development and Therapy,Respiratory Medicine and Thorax. Dr. Trow also served on the Steering Committee for the Pulmonary Vascular Disease Network for the American College of Chest Physicians from 2006-2013, as well as on the Steering Committee for the Scleroderma Foundation’s National Echocardiography Education Campaign. He was recently appointed to the Scientific Leadership Council of the Pulmonary Hypertension Association and was appointed to the ACCP Task force to update the ACCP Evidence-Based Guidelines in the Pharmcologic Therapy of Pulmonary Arterial Hypertension.
Dr. Trow’s research interests are in the arena of clinical biomarkers in pulmonary hypertension. He has published widely in such journals as Chest, the Proceedings of the American Thoracic Society, Clinical Pulmonary Medicine, the Journal of Biological Chemistry, Heart&Lung: The Journal of Acute Critical Care, the Journal of Immunology, the American Journal of Physiology, the American Journal of Medicine ,Clinic in Chest Medicine, Vascular Health and Risk Management, Therapeutic Advances in Respiratory Disease, Respiratory Medicine and Thorax.
W. Michael Alberts
Moffitt Cancer Center, Professor of Oncology and Medicine, Department of Oncologic Sciences, University of South Florida College of Medicine